The metabolic syndrome: prevalence, CHD risk, and treatment.
about
Impact of Fenofibrate on Type 2 Diabetes Patients with Features of the Metabolic Syndrome: Subgroup Analysis From FIELD.The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic reviewEffect of Walking Exercise on Changes in Cardiorespiratory Fitness, Metabolic Syndrome Markers, and High-molecular-weight Adiponectin in Obese Middle-aged Women.Metabolic syndrome in the pediatric population: a short overviewThe interaction effects of aerobic exercise training and vitamin D supplementation on plasma lipid profiles and insulin resistance in ovariectomized rats.The effects of sex, metabolic syndrome and exercise on postprandial lipemia.Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications.Early detection of renal disease/microalbuminuria in patients with the cardiometabolic syndrome.Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease.Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance.Patterns of relationships between cardiovascular disease risk factors and neurocognitive function in African Americans.Atherosclerosis, diabetes and lipoproteins.A systematic review of baseline psychosocial characterisation in dietary randomised controlled trials for weight loss.The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model.Hypolipidemic activities of Ficus racemosa Linn. bark in alloxan induced diabetic rats.Metabolic Syndrome Patients Have Lower Levels of Adropin When Compared With Healthy Overweight/Obese and Lean Subjects.Prevalence of Metabolic Syndrome and Its Individual Components Among Midwestern University Students.Exercise training dose differentially alters muscle and heart capillary density and metabolic functions in an obese rat with metabolic syndrome.Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients.Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial.Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients.The relationship between periodontitis and metabolic syndrome among a Korean nationally representative sample of adultsInfluence of maternal nutrition on the metabolic syndrome and cardiovascular risk in the offspring
P2860
Q33940875-D1EBEE85-F799-4888-A917-2A7E3FCEF92EQ34435090-56E04B0C-ACDB-4D72-ADC5-467906226F1CQ34567216-96110878-C1CA-4F82-876C-2A9E4598FB92Q34985768-E1616C82-BF51-466E-A268-D2CA02FC506CQ36218598-01F6E5E9-0E77-4382-B539-43FFED59E211Q36501367-B3370429-9C25-451E-A864-365181E9FDFCQ36790316-8DFF2707-72AC-4CCA-BD95-37CC407C3E9FQ36904439-CFDB4474-A841-4CA7-AC13-6D7C61B2BDB6Q37004049-67A2BF23-A3C2-4365-8F65-50F5E30A16DDQ37219139-6E8CA387-D729-4673-9743-9B15AC81FDF5Q37243950-1CCBF5CC-DEE5-42E1-BF60-7F4626A47923Q37770113-7814D237-44E6-4B8F-9CEC-9DFEF858C098Q38101209-89EAD981-75D1-4887-B7FD-1FDB7935A684Q38349243-09A7557D-BA5C-4879-BF6E-1D5CAC3815CBQ42923344-DB2742C2-8334-4301-A594-0FF500E35FFCQ47100557-2A6E3CEC-D3A2-4C16-92A6-E67991665167Q47578175-2515EAAA-28ED-42BB-B369-123BFBB9BD47Q48332051-3E526C9F-6CB6-46EE-9D36-CCEB27394053Q51364734-957AF9D5-A9A2-47AB-8C4F-2C35537B0E44Q53135887-27576D01-966E-4BF0-9C19-3EBCF91733E6Q55315345-99874572-606C-4342-B76A-401A3DACA0F2Q57226315-DD2A446B-6086-4708-A1DE-9486A34559E5Q57659859-4F57C311-FCBC-4165-A3B4-94B1002D310F
P2860
The metabolic syndrome: prevalence, CHD risk, and treatment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The metabolic syndrome: prevalence, CHD risk, and treatment.
@ast
The metabolic syndrome: prevalence, CHD risk, and treatment.
@en
type
label
The metabolic syndrome: prevalence, CHD risk, and treatment.
@ast
The metabolic syndrome: prevalence, CHD risk, and treatment.
@en
prefLabel
The metabolic syndrome: prevalence, CHD risk, and treatment.
@ast
The metabolic syndrome: prevalence, CHD risk, and treatment.
@en
P1476
The metabolic syndrome: prevalence, CHD risk, and treatment.
@en
P2093
Cinzia Sarti
John Gallagher
P304
P356
10.1016/J.JDIACOMP.2005.06.014
P577
2006-03-01T00:00:00Z